Year: 2022

EDEN PRAIRIE, Minn., Nov. 21, 2022 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced that the Company will participate in the Piper Sandler 34th Annual Healthcare Conference on December 1st, 2022.   Miromatrix’s management is scheduled to present at the Piper Sandler 34th Annual Healthcare Conference on Thursday, December 1st, 2022 at 11:00 am ET. Interested parties can access the live and archived webcast here. About MiromatrixMiromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients’ lives. The Company has developed a proprietary perfusion technology...

To Nasdaq Copenhagen Additional terms for Nykredit‘s and Totalkredit‘s auctions With reference to stock exchange announcement dated 3 November 2022 regarding Nykredit’s and Totalkredit’s auctions, we hereby announce the final offering in the floating rate mortgage bond in EUR (DK0009538571). The auction will take place on Wednesday 23 November 2022 where the offered amount will be EUR 230 million. Questions may be addressed to Nykredit Realkredit A/S, Group Treasury, Christian Mauritzen tel +45 44 55 10 14.AttachmentAdditional terms for Nykredit’s and Totalkredit’s auctions

All amounts expressed in US dollars TORONTO, Nov. 21, 2022 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) (“Barrick,” the “Company” or the “Offeror”) today announced the expiration and final results of its previously announced tender offer (the “Offer”) to purchase for cash any and all of its 5.250% Notes due 2042 (the “Notes”). The Offer was made pursuant to the terms and subject to the conditions set forth in the Offer to Purchase dated November 14, 2022 relating to the Notes (the “Offer to Purchase”) and the accompanying notice of guaranteed delivery (the “Notice of Guaranteed Delivery” and, together with the Offer to Purchase, the “Tender Offer Documents”). Capitalized terms used but not defined in this announcement have the meanings given to them in the Offer to Purchase. Set forth in the table below is the...

Wi-Fi NOW Supports and Promotes All Things Wi-Fi to Make High-Quality, High-Performance W-Fi Available to Everyone, Everywhere Akoustis Adds to Wi-Fi NOW’s Growing, Global Thought LeadershipCharlotte, N.C., Nov. 21, 2022 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced that it has joined the Wi-Fi NOW industry association as an Official RF Filter Partner, alongside major thought leaders including Cisco, Eero, Linksys, Intel, Netgear, and many more. Wi-Fi NOW was founded in 2015 as a media, event, training, and advisory organization dedicated to serving the global Wi-Fi industry. Since then, Wi-Fi NOW has quickly grown to support hundreds...

HOUSTON, Nov. 21, 2022 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced that Gail McIntyre, Ph.D., DABT, Chief Executive Officer and Rudy Howard, Chief Financial Officer will be presenting a corporate overview and participating in 1×1 meetings at the Piper 34th Annual Healthcare Conference being held on November 29 – December 1, 2022 in New York, NY.Piper 34th Annual Healthcare Conference – November 29-December 1, 2022Title: Aravive (ARAV) Company PresentationDate: Wednesday, November 30, 2022Time: 3:30 – 3:50 PM ESTParticipant: Gail McIntyre, Ph.D., DABT, CEO, AraviveWebcast: Registration Link – Click HereA replay of the session will be available following the conference through the Aravive...

CINCINNATI, Nov. 21, 2022 (GLOBE NEWSWIRE) — Paycor HCM, Inc. (Nasdaq: PYCR) (“Paycor”), a leading provider of human capital management (HCM) software, today announced that the company will participate in the Credit Suisse 26th Annual Technology Conference in Scottsdale, Arizona. The presentation is scheduled for Tuesday, November 29, 2022 at 11:40 am Mountain Time (1:40 pm Eastern Time). The presentation will be webcast live and accessible for replay for a limited time under the “Events & Presentations” section of Paycor’s Investor Relations website at https://investors.paycor.com/. About Paycor Paycor’s human capital management (HCM) platform modernizes every aspect of people management, from recruiting, onboarding and payroll to career development and retention, but what really sets us apart is our focus...

TORONTO, Nov. 21, 2022 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSX-V: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) is pleased to announce results from the first 15 Feasibility Study drill holes on its flagship Cordero silver project (“Cordero” or “the Project”) located in Chihuahua State, Mexico. These holes consisted of upgrade and expansion drilling of the proposed open pit and were drilled subsequent to the data cut-off date for the Pre-Feasibility Study (“PFS”). The Pre-Feasibility Study is progressing well and remains on track to be delivered in early 2023. Highlight intercepts from this current set of drill holes include:77 m averaging 126 g/t AgEq1 (46 g/t Ag, 0.08 g/t Au, 0.7% Pb and 1.4% Zn) from 218 m and 22 m averaging 265 g/t AgEq1 (83 g/t Ag, 0.10 g/t Au, 1.8% Pb and 3.2% Zn) from 374 m in hole C22-656. 96...

CHATHAM, N.J., Nov. 21, 2022 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today announced that Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals, will deliver an oral presentation at the World Antiviral Congress 2022, which will be held in San Diego, Calif., November 28 – December 1, 2022. A copy of the presentation will be available under the Scientific Presentations tab of the Tonix website at www.tonixpharma.com following the conference. Additional meeting information can be found on the World Antiviral Congress website here. Oral Presentation DetailsTitle: Development of fully human monoclonal antibodies against SARS-CoV2 using peripheral B-cells from COVID-19 survivors  Location: Loews Coronado Bay Resort, San Diego, Calif.Date: November...

Fosgonimeton demonstrates improvement on diverse biomarkers of neurodegeneration BOTHELL, Wash., Nov. 21, 2022 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that additional biomarker data from the completed, exploratory ACT-AD Phase 2 study of fosgonimeton (ATH-1017) in patients with mild-to-moderate Alzheimer’s disease was selected as a late-breaking poster presentation at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) conference, taking place November 29 – December 2, 2022, in San Francisco, California and virtually. Presentation Details: Title: Fosgonimeton provides congruent benefit on diverse biomarkers of neurodegeneration, significantly correlating...